[HTML][HTML] North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension

JR Boike, BG Thornburg, SK Asrani, MB Fallon… - Clinical …, 2022 - Elsevier
Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic
hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and …

Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis

G Mukhiya, X Zhou, X Han, D Jiao, G Pokhrel, Y Li… - Scientific Reports, 2022 - nature.com
This study was performed to evaluate the outcome of endovascular intervention therapy for
Budd-Chiari syndrome (BCS) and compare recanalization, transjugular intrahepatic …

Transjugular intrahepatic portosystemic shunt in the treatment of Budd–Chiari syndrome: a critical review of literatures

X Qi, M Yang, D Fan, G Han - Scandinavian journal of …, 2013 - Taylor & Francis
An increasing number of patients with Budd–Chiari syndrome (BCS) have undergone
transjugular intrahepatic portosystemic shunt (TIPS). However, the critical role of TIPS in the …

Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial

L Wang, Z Xiao, Z Yue, H Zhao, Z Fan, M Zhao, F He… - Scientific reports, 2016 - nature.com
We conducted a single-center randomized trial to compare the efficacy of 8 mm Fluency
covered stent and bare stent in transjugular intrahepatic portosystemic shunt (TIPS) for …

Survival and prognostic indicators of Budd–Chiari syndrome: a systematic review of 79 studies

X Qi, W Ren, Y Wang, X Guo, D Fan - Expert Review of …, 2015 - Taylor & Francis
This paper aimed to systematically review the survival of Budd–Chiari syndrome and to
identify the most robust prognostic predictors. Overall, 79 studies were included. According …

[HTML][HTML] TIPS 术后支架功能障碍的研究现状

梁艳平, 唐映梅, 杨晋辉, 尤丽英 - 世界华人消化杂志, 2013 - wjgnet.com
经颈静脉肝内门体分流术(transjugular intrahepatic portosystemic shunt, TIPS)
目前已经成为治疗门脉高压并发症的有效方法, 特别是门静脉高压导致的急性食管胃底静脉曲张 …

[HTML][HTML] Effects of percutaneous transhepatic interventional treatment for symptomatic Budd-Chiari syndrome secondary to hepatic venous obstruction

B Zhang, ZB Jiang, MS Huang, KS Zhu, JS Qian… - Journal of Vascular …, 2013 - Elsevier
Objective Budd-Chiari syndrome (BCS) is a rare and life-threatening disorder characterized
by hepatic venous outflow obstruction. The management of BCS includes anticoagulation …

Pattern of vascular involvement in Egyptian patients with Budd-Chiari syndrome: relation to etiology and impact on clinical presentation

MA Sakr, SM Abdelhakam, HM Dabbous… - Annals of …, 2018 - medigraphic.com
ABSTRACT Introduction and aim. Budd-Chiari syndrome (BCS) is caused by hepatic venous
outflow obstruction. This work aims to analyze the pattern of vascular involvement in …

Procalcitonin as a Biomarker for Early Trans-jugular Intrahepatic Porto-Systemic Shunt (TIPS) Stent Occlusion Prediction in Patients with Budd Chiari Syndrome

MA Sakr, EM El Gindy, NA Abdelkader… - Afro-Egyptian Journal …, 2024 - journals.ekb.eg
Background and study aim: One of the serious complications infrequently reported with
transjugular intrahepatic portosystemic shunt (TIPS) stent endovascular infection is …

Transjugular approach for successful recanalization and stenting for inferior vena cava stenosis

BC Srinivas, AP Singh, CM Nagesh, B Reddy… - Cardiovascular …, 2013 - Springer
Budd-Chiari syndrome is a rare disease characterized by obstruction of outflow in the
hepatic vein and/or the inferior vena cava (IVC). Percutaneous transluminal angioplasty and …